Dr. Cuddy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
75 Francis St
Boston, MA 02115Phone+1 617-732-5500Fax+1 857-307-0899
Education & Training
Brigham and Women's HospitalFellowship, Cardiovascular Disease, 2016
University College of Dublin National Univ SOMClass of 2008
Certifications & Licensure
MA State Medical License 2016 - 2026
ME State Medical License 2020 - 2021
American Board of Internal Medicine Internal Medicine
Clinical Trials
- Exercise Training in Transthyretin Cardiac Amyloidosis Start of enrollment: 2024 May 01
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Development of Imaging Endpoints for Clinical Trials in AL and ATTR Amyloidosis: Proceedings of the Amyloidosis Forum.Sharmila Dorbala, Rosalyn Adigun, Kevin M Alexander, Michela Brambatti, Sarah A M Cuddy
JACC. Cardiovascular Imaging. 2025-02-20 - Silencers versus stabilizers in amyloid cardiomyopathy. Are we asking the wrong questions?Rodney H Falk, Sarah A M Cuddy, Osnat Itzhaki Ben Zadok
European Journal of Heart Failure. 2025-02-13 - Current practices in amyloidosis imaging with bone-avid tracer cardiac scintigraphy.Sarah A M Cuddy, Omar Abou-Ezzeddine, Linda P Giering, Sharmila Dorbala, Jamieson M Bourque
Journal of Nuclear Cardiology. 2025-02-01
Press Mentions
Cover Story | Transformative Trends in CV Medicine for 2025January 6th, 2025- Before a Cardiomyopathy Diagnosis, TTR Destabilization Portends Higher MortalityDecember 12th, 2024
- Better Amyloidosis Treatments Expand Options and CuresDecember 6th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
